RICHMOND, Va., July 25 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it will host a conference call on Friday, August 8th at 8:30 AM ET, to discuss its results for the second quarter 2008. Insmed intends to issue its quarterly financial results press release before the market opens on August 8th.
To participate in the live conference call, please dial 866-202-1971 (U.S. callers) or 617-213-8842 (international), and provide passcode 85261742. A live webcast of the call will also be available at http://phx.corporate-ir.net/playerlink.zhtml?c=122332&s=wm&e=1907655. Please allow extra time prior to the webcast to register, download and install any necessary audio software.
The webcast will be archived for 30 days, and a telephone replay of the call will be available for seven days, beginning at 10:30 AM ET on August 8th at 888-286-8010 (U.S. callers) or 617-801-6888 (international), using passcode 46396392.
Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.
This release contains forward-looking statements which are made
pursuant to provisions of Section 21E of the Securities Exchange Act of
1934. Investors are cautioned that such statements in this release,
including statements relating to planned clinical study design, regulatory
and business strategies, strategic alternatives, plans and objectives of
management and growth opportunities for existing or proposed products,
constitute forward-looking statements which involve risks and uncertainties
|SOURCE Insmed Inc.|
Copyright©2008 PR Newswire.
All rights reserved